Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations

Yuan Chen,Manlin Zeng,Ke Zhang,Longying Ye,Shuting Jiang,Kaiqi Jia,Lihong Yang,MingShan Wang

DOI: https://doi.org/10.1097/mbc.0000000000001330

2024-11-13

Blood Coagulation & Fibrinolysis

Abstract:The purpose of this study was to determine the molecular basis of a Chinese family with factor XI (FXI) deficiency.

hematology

What problem does this paper attempt to address?

The Molecular Genetic Analysis of Coagulation Factor XI (FXI) Deficiency in Two Chinese Patients

Rong-Fu Zhou,Qian Li,Min Zhou

DOI: https://doi.org/10.1182/blood-2018-99-118232

IF: 20.3

2018-01-01

Blood

Abstract:Objective: To investigate the molecular pathogenesis of two coagulation factor XI (FXI) deficiency patients.
A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree

Songsong Lu,Weicheng Lin,Huijuan Ji,Ming Su,Xiaotao Zhao,Chengbin Wang

DOI: https://doi.org/10.1159/000507689

2020-06-29

Acta Haematologica

Abstract:Background: Mutations in the F10 -coding gene can cause factor X (FX) deficiency, leading to abnormal coagulation activity and severe tendency for hemorrhage. Therefore, identifying mutations in F10 is important for diagnosing congenital FX deficiency. Methods: We studied a 63-year-old male patient with FX deficiency and 10 of his family members. Clotting and immunological methods were used to determine activated partial thromboplastin time (aPTT), prothrombin time (PT), thrombin time (TT), fibrinogen levels, FX activity, and FX antigen levels. The platelet count was determined. A mixing study was performed to eliminate the presence of coagulation factor inhibitors and lupus anticoagulant. Mutations were searched using whole-exome sequencing and certified by Sanger sequencing. Results: Genetic analysis of the proband identified two single-base substitutions: c.1085G>A (p.Ser362Asn) and c.1152C>A (p.Tyr384Ter, termination codon, caused by the DNA sequence TAA). His FX activity and antigen levels were 1.7% and 408.53 pg/mL, respectively; aPTT and PT were 52.3 and 48.0 s, respectively. One brother had the same compound heterozygous mutations, and his FX activity and antigen levels were 1.3% and 465.47 pg/mL, respectively; his aPTT and PT were 65.2 and 54.5 s, respectively. His mother, another brother, and one sister were heterozygous for c.1085G>A (p.Ser362Asn), and his daughter and grandson (6 years old) were heterozygous for c.1152C>A (p.Tyr384Ter). Conclusion: The heterozygous variants p.Ser362Asn or p.Tyr384Ter indicate mild FX deficiency, but the compound heterozygous mutation of the two causes severe congenital FX deficiency and bleeding. Genetic analysis of these two mutations may help characterize the bleeding tendency and confirm congenital FX deficiency.

hematology
[Phenotype and genotype analysis for a consanguineous pedigree with combined coagulation factor VII and X deficiency].

Yanhui Jin,Mingshan Wang,Yingyu Wang,Xiaoli Yang,Lihong Yang,Yaosheng Xie,Haixiao Xie,Liqing Zhu,Fangyou Yu

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2014.01.004

2014-01-01

Abstract:OBJECTIVE:To identify potential mutations and explore the molecular mechanism underlying combined inherited coagulation factors VII(FVII) and X(FX) deficiency for a family featuring consanguineous marriage between maternal cousins. METHODS:Prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, FVII activity (FVII:C), FX activity (FX:C), FVII antigen (FVII:Ag), FX antigen (FX:Ag) and other coagulant parameters of the proband and 5 family members were measured. Potential mutations in exons, exon-intron boundaries and 5', 3' untranslated sequences of F7 and F10 genes were screened by polymerase chain reaction and direct sequencing. Suspected mutations were confirmed by sequencing the opposite strand. RESULTS:PT and APTT of the proband were obviously prolonged to become 76.4 s and 60.2 s, respectively. FVII:C, FVII:Ag,FX:C and FX:Ag of the proband were obviously reduced to become 4%, 6%, 6% and 33%, respectively. Both PT and APTT of her grandmother, father, mother and daughter were slightly prolonged, which have measured 16.4 s, 15.8 s,16.9 s, 16.5 s, and 44.0 s, 42.1 s, 41.1 s, 43.5 s, respectively. And their FVII:C (34%, 39%, 31%, 40%, respectively), FX:C (50%, 58%, 47%, 42%, respectively) and FX:Ag (51%, 54%, 58%, 47%, respectively) were slightly reduced, while FVII:Ag was in the normal range. The coagulant parameters of her younger brother were within normal range. Two homozygous mutations, g.11267C to T in exon 8 of F7 gene, which resulted in an Arg277Cys substitution, and g.28139G to T in exon 8 of F10 gene which led to a Val384Phe substitution, were identified in the proband. The proband's grandmother, parents and daughter were heterozygous for both Arg277Cys and Val384Phe mutationss. Wild-type alleles of both F7 and F10 genes were also found in the younger brother. CONCLUSION:A homozygous Arg277Cys mutation and a Val384Phe mutation have been respectively identified in the F7 and F10 genes, which can explain the low levels of FVII and FX in this family. The former has been inherited from the consanguineous parents.
Genetic Analysis in Factor XI Deficient Patients from Central China: Identification of One Novel and Seven Recurrent Mutations.

Hui Liu,Hua-Fang Wang,Liang Tang,Yan Yang,Qing-Yun Wang,Wei Zeng,Ying-Ying Wu,Zhi-Peng Cheng,Bei Hu,Tao Guo,Yu Hu

DOI: https://doi.org/10.1016/j.gene.2015.02.021

IF: 3.913

2015-01-01

Gene

Abstract:Factor XI (FXI) deficiency is a rare bleeding disorder with a range of manifestations from asymptomatic to trauma related bleeding. To identify mutations in FXI-deficient patients and characterize the phenotype-genotype relationship, we studied six patients and their 18 family members in central China. Five patients were identified by presurgical or routine laboratory screening but had no bleeding symptoms. Only one patient exhibited excessive injury- and surgical-related bleeding. Eight mutations were detected, including five nonsense mutations (p.Tyr369*, p.Arg72*, p.Gln281*, p.Trp519*, and p.Trp246*), two missense mutations (p.Thr40Ile and p.Ala430Thr), and a 4-bp deletion in a splice site (c.1136-4delGTTG); one mutation was novel (p.Thr40Ile). In vitro, the p.Thr40Ile mutant protein exhibited impaired secretion and function. Five of the patients were homozygous or compound heterozygous, but only one nonsense mutation was found in Patient 2. In these patients, bleeding tendency was not correlated with FXI levels or with a single heterozygous mutation. Thrombin generation tests could not distinguish the bleeder from non-bleeders. In conclusion, we reported 8 mutations in the FXI gene (F11) leading to FXI deficiency. Moreover, the functional consequences of a novel mutation leading to FXI deficiency have been elucidated. More cases are needed to find any signature of founder effect in the Chinese population and its potential relationship with other Asian population.
[FXI Gene Mutations in Two Pedigrees of Congenital Clotting Factor XI Deficiency].

Wen-Man Wu,Qiu-Lan Ding,Xue-Feng Wang,Qi-Hua Fu,Wen-Bin Wang,Jing Dai,Yi Fang,Rong-Fu Zhou,Shuang Xie,Yi-Qun Hu,Zhi-Xiang Sheng,Hong-Li Wang,Zhen-Yi Wang

2004-01-01

Abstract:OBJECTIVES:To identify the FXI gene mutations in two Chinese pedigrees of congenital factor XI deficiency.METHODS:The peripheral blood samples were collected from the probands and their family members and the plasma FXI:C and FXI:Ag were determined. All the exons and exon-intron boundries of FXI gene were amplified with PCR and sequenced thereafter.RESULTS:A nonsense mutation Trp228stop and two missense mutations Glu323Lys and Leu172Pro were disclosed in the two pedigrees. All mutations existed in a heterozygous state.CONCLUSION:The FXI gene mutations Trp228stop, Glu323Lys and Leu172Pro attribute to the pathogenesis of the congenital factor XI deficiency in Chinese. The Leu172Pro is identified for the first time.
Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

Qian Li,Hui Zeng,Yong Xu,Min Zhou,Bing Chen,Rong-Fu Zhou

DOI: https://doi.org/10.1182/blood-2018-99-118105

IF: 20.3

2018-01-01

Blood

Abstract:The objective is to identify the gene mutations responsible for the deficiency of factor XI (FXI) in a Chinese pedigree. The FXI activity was tested with clotting assay. The F11 gene was amplified by PCR with direct sequencing. ClustalX-2.1-win and three online bioinformatics softwares were used to study the conservatism and harm of the mutation. The proband was a 70-year-old male and had a prolonged APTT of 67.8s. The corrected APTT was 28.3s and he had reduced FXI: activity of 0.8%. His son and daughter had normal APTT of 26s and 27.3s and FXI:C of 72% and 75%, respectively. DNA sequencing analysis showed the proband carried a compound heterozygous g.841C>T and g.1556G>A mutation , resulting in Ser281Stop and Trp519Stop, respectively, which caused premature termination of transcription in the F11. His son had the heterozygous g.841C>T mutation of F11 and his daughter had the heterozygous g.1556G>A mutation of F11. The three bioinformatics softwares indicated that the mutation had affected the function of the protein. The two nonsense mutations had been reported previously in different patient, but this is the first time to be reported in the proband, which was responsible for the decrease of FXI: activity.
Molecular analysis of the discrepancy between the genotypes and phenotypes in a inherited coagulation factor Ⅶ deficiency.

HUANG He,HU Huixian

DOI: https://doi.org/10.3969/j.issn.1006-2785.2007.09.001

2007-01-01

Abstract:Objective To explore the relationship between the genotypes and phenotypes in a inherited FⅦ deficiency pedigree. Methods Factor VII coagulation (FⅦ:C) and Factor X coagulation (FX: C) were measured in a inherited FⅦ deficiency pedigree. FⅦ gene mutations were detected in the proband and her family members by PCR and DNA sequencing. The relation between the detective results and the clinical manifestation were analyzed. Results Homozygote of C→T transition at position 10827 in exon 8 resulting in Arg304Trp transition was identified in the proband and two siblings. High level of FX: C was also found in the proband and two siblings, but all had no symptoms of bleeding. Conclusion Not only the level of FⅦ:C but also the level of FX: C might be involved in the clinical manifestation in the patients with inherited FⅦ: C deficiency.
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency

Haiyue Zhang,Dongli Pan,Weifeng Shen

DOI: https://doi.org/10.1097/mbc.0000000000001044

2021-05-10

Abstract:The aim of this study was to elucidate the molecular defects of a Chinese family with hereditary coagulation factor XII (FXII) deficiency. The FXII activity (FXII:C) and FXII antigen (FXII:Ag) levels were measured by clotting assay and ELISA, respectively. To identify mutations, the F12 gene sequencing was carried out. ClustalX-2.1-win and four online bioinformatics tools were applied to study the conservatism and harm of the mutation. The proband's FXII:C and FXII:Ag were 3 and 4%, respectively. Sequencing analysis revealed compound heterozygous mutations, including the deletion mutation (c.130delG) resulting in p.E26Sfs∗50 and the missense mutation (c.1561G>A) resulting in p.E502K. Bioinformatics indicated that mutations probably disrupt the function of the FXII protein. The c.130delG heterozygous deletion variation and the c.1561G>A heterozygous missense variation were responsible for the reduction of FXII:C in this family, of which c.130delG was first reported in the world.

hematology
Genetic Analysis of a Pedigree with Combined Factor XII and Factor XI Deficiency

Xu Ye,Ying Feng,Qiulan Ding,Jing Dai,Xuefeng Wang

DOI: https://doi.org/10.1097/mbc.0b013e3283433147

2010-01-01

Blood Coagulation & Fibrinolysis

Abstract:The objective of the present study was to identify the gene mutations of factor XI (FXI) and factor XII (FXII) in a Chinese pedigree with combined congenital FXI and FXII deficiencies. The proband was a 40-year-old woman with deficiency in both FXI (49%) and FXII (0%) activities. Blood samples from 10 other members of her family were collected and used for detection of FXI, FXII activities (FXI: C, FXII: C) and antigen levels. Genetic analysis to detect mutations in FXI, FXII genes was also performed. The proband's mother, three brothers, two sisters, her son and her daughter all have lowered FXII: C. Furthermore, her mother and one of her brothers also have lowered FXI: C. Gene sequencing for FXI in affected members revealed a heterozygous C23179T point mutation in exon 11 resulting in substitution of arginine 396 by cysteine. Gene sequencing for FXII revealed a C46T in the promoter region and a deletion mutation of two nucleotides CA at position 9160 and 9161 in exon 5. The deletion mutation can lead to frameshift mutation and premature termination of transcription in exon 6. We found a new heterozygous missense mutation in the FXI gene and a new nonsense mutation of two nucleotides deletion which caused frameshift mutation and premature termination of transcription in the FXII gene in a Chinese family with combined FXI and FXII deficiencies.
Study on the molecular mechanism of the inherited factor X deficiency in three unrelated families

Qiong CHEN,Jia-wei ZHOU,Qiu-lan DING,Xue-feng WANG,Jing DAI,Dan-dan HUANG,Ye-ling LU,Guan-qun XU,Li-wei ZHANG,Xiao-dong XI,Hong-li WANG

DOI: https://doi.org/10.3760/cma.j.issn.1009-9158.2010.09.007

2010-01-01

Abstract:Objective To identify the clinical features, the molecular diagnosis and the molecular mechanism of three unrelated factor X deficiency families. Methods Three probands were male and the diagnosis was validated by coagulant parameters. The F X coagulation activity ( F X∶ C ) and antigen (FX∶ Ag) were tested by clotting test and ELISA method. The cross-corrected test was used to rule out the inhibitor of FX in plasma. Thrombin generation test was evaluated. The antigen and the molecule weight of the FX in plasma were measured with western blotting. Gene mutations were analyzed in the probands and their family members with PCR and DNA sequencing. FX expression plasmids were constructed and transientby being transfected into 293T cells. FX: C and FX: Ag of the expression products were tested. Results APTT and PT in proband 1 were obviously prolonged, 113.4 s and 62.3 s, respectively. And there was no inhibitor in plasma. The thrombin generation was lower compared to normal reference. APTT and PT in proband 2 were 56. 5 s and 28.7 s. There was no inhibitor in the plasma. The thrombin generation was 1 101.5 nmol · min. APTT and PT in proband 3 were 117.3 s and 44. 3 s. The thrombin generation was 782.5 nmol · min. FX∶ C and FX∶ Ag in proband 1 were 1.4% and 3.6%, with a homozygous mutation in FX gene (Ser425→Pro). In vitro expression of the mutation showed a normal synthesis in the cell but secretion dysfuntion. In proband 2 F X: C and F X: Ag were 2. 2% and 5. 5%, with two heterozygous mutations in FX gene (Ala-29→Pro and Phe324→Leu). The Ala-29 → Pro mutation led to significantly reduced expressions of FX in both cell lysate and cell culture supernatants compared to wild-type plasmid,(41.32 ±5.21 )% and(6. 30 ± 1.84)% respectively. However Phe324→Leu mutation almost did not affect the FX synthesis. FX: C and FX: Ag in proband 3 were 2. 2% and 35%, with two heterozygous mutations in FX gene( Ala235→Thr and Arg347→Cys). The expressions of these two mutant FX proteins in cell lysate were similar to those of wild-type but obviously lower in the supernatant. Conclusions Five mutations of F X gene are found in this study. These mutations (Ser425Pro, Phe324Leu, Ala235Thr and Arg347Cys)can not affect F X protein synthesis. However Ala-29Pro mutation can reduce F X protein synthesis and cause secretion dysfunction.
[The Inherited Coagulation Factor XI Deficiency Caused by Intronic Mutation IVS J-4delgttg].

Shuang Xie,Hong-Li Wang,Xue-Feng Wang,Wen-Man Wu,Rong-Fu Zhou,Wen-Bin Wang,Yi-Qun Hu,Zhen-Yi Wang

DOI: https://doi.org/10.3760/j:issn:0253-2727.2005.03.005

2005-01-01

Abstract:OBJECTIVE:To identify gene defect in a Chinese pedigree of hereditary coagulation factor XI (FXI) deficiency.METHODS:The peripheral blood samples were collected from the proband and her family members. The plasma PT, APTT, FXI:C and FXI:Ag were assayed. The FXI gene exons and exon-intron boundaries of the proband were amplified by PCR and then sequenced directly. The mRNA of FXI in the peripheral blood was analyzed with RT-PCR.RESULTS:The proband and some of her family members had prolonged APTT. The plasma FXI:C and FXI:Ag of the proband, her brother and her parents were lower than 10% and 50% of the normal values, respectively. Nucleotide sequence analysis revealed that the proband and her brother had a homozygous mutation of IVS J-4delgttg in FXI gene. The mutation was inherited from her parents who were heterozygotes. The mutation was not found in 60 normal subjects. No FXI mRNA was detected in peripheral blood sample of the proband.CONCLUSION:The IVS J-4delgttg is a novel mutation causing FXI deficiency, which may interfere with mRNA splicing.
Inherited coagulation factor X deficiency caused by two novel mutations in factor X gene]

Wen-bin Wang,Hong-li Wang,Xue-feng Wang,Qi-hua Fu,Rong-fu Zhou,Shuang Xie,Yi-qun Hu,Zhen-yi Wang

2004-01-01

Abstract:To explore the molecular mechanisms involved in a pedigree with inherited coagulation factor X (FX) deficiency.The activated partial thromboplastin time (APTT), prothrombin time (PT), FX activity (FX:C) and FX antigen (FX:Ag) test were adopted for phenotype diagnosis. All the 8 exons, intron/exon boundaries and the 5'untranslated regions (UTR) of the FX gene were amplified by polymerase chain reaction (PCR) from the genomic DNA extracted from the peripheral blood of the propositus. The PCR products were screened by direct sequencing. The mutation was confirmed by allele specific PCR (ASPCR).The phenotype of the propositus was identified as FX deficiency (type II). Two novel FX gene mutations were detected in the propositus: one was a donor site splice mutation in intron 1 (IVS1 + 1G-->A), another was a missense mutation 1185G-->A in exon 8 (Arg347His).The FX deficiency of the propositus is caused by double heterozygous mutations IVS1 + 1G-->A and Arg347His.
Molecular Defects in the Factor X Gene Caused by Novel Heterozygous Mutations IVS5+1G>A and Asp409del.

J. W. Zhou,Q. Liang,Q. Chen,Y. Xie,Q. L. Ding,X. F. Wang,X. D. Xi,H. L. Wang

DOI: https://doi.org/10.1111/j.1365-2516.2012.02933.x

2012-01-01

Haemophilia

Abstract:Factor X (FX) deficiency is a rare autosomal-recessive bleeding disorder caused by diverse mutations in the F10 gene. To investigate the molecular basis of severe FX deficiency in a mildly hemorrhagic patient, variants of the F10 gene were detected by sequencing. A missense mutation was analysed by in vitro expression and modelling analysis, and a splice mutation using ectopic transcript analysis. The levels of activity of FX (FX:C) were <1% in both intrinsic and extrinsic pathway assays and 1.71% in chromogenic assay, the level of FX antigen (FX:Ag) was 53.36% in the proband. Two novel heterozygous mutations (IVS5+1G>A and Asp409del) were identified in the F10 gene. Ectopic transcript expression combined with informative marker (heterozygous Asp409del) analysis of the splice mutation (IVS5+1G>A) revealed and confirmed that the transcript from the mutated allele was absent, likely caused by the nonsense-mediated mRNA decay pathway. In vitro expression analysis showed that the Asp409del mutant led to a loss of enzymatic activity rather than impaired expression. Molecular modelling analysis confirmed that the Asp409del mutant dramatically altered the conformation of the 185-189 loop and impaired binding of the loop to sodium ions (Na(+) ), diminishing the enzymatic activity of FXa. This is the first report to clarify the molecular mechanisms of two naturally occurring F10 gene variants that cause severe FX deficiency.
Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China

Yanyan Shao,Yanan Cao,Yeling Lu,Jing Dai,Qiulan Ding,Xuefeng Wang,Xiaodong Xi,Hongli Wang

DOI: https://doi.org/10.1016/j.bcmd.2016.01.004

Abstract:Congenital factor XI (FXI) deficiency is a rare bleeding disorder with unpredictable bleeding tendency. Few studies in a large cohort have been reported regarding associations between FXI activity (FXI:C) or genotypes and bleeding symptoms currently. This study characterized clinical manifestations and mutation spectrum of 57 subjects with FXI deficiency in China. Clinical data were collected and mutations were identified by direct sequencing and determined by mRNA analysis. The result revealed bleeding symptoms were only found in 12 patients (12/57, 21.1%) with severely reduced FXI:C, and prolonged bleeding post injury/surgery as well as easy bruising were the commonest bleeding manifestations presented in respective 5 cases (5/12, 41.7%). A total number of 37 mutations were identified including 19 missense mutations, 9 nonsense mutations, 6 splice site mutations and 3 small deletions. Among them, 4 missense mutations, 5 splice mutations, 3 small deletions and a nonsense mutation were newly detected. W228*, G400V, Q263* and c.1136-4delGTTG with a total frequency of 48.3% were the most four common mutations in Chinese patients. RT-PCR analysis was carried out and confirmed that both c.596-8T>A and c.1136-4delGTTG were pathogenic due to frameshift resulting in respective truncated proteins. Our findings suggested clinical manifestations had little to do with FXI:C or genotypes, which required further study. This study, the largest investigation of FXI deficiency in China revealed that the F11 mutation spectrum of Chinese population was distinct from those of other populations earlier established.
Hereditary Coagulation Factor VII Deficiency Caused by Novel Compound Heterozygous Mutations C.572-1G>a and C.1037a>c in a Chinese Pedigree

Lindan Wei,Chenxi Fan,Xin Sun,Xin Wang,Hongsong Yu

DOI: https://doi.org/10.1016/j.gene.2024.148788

IF: 3.913

2024-01-01

Gene

Abstract:Hereditary coagulation factor VII (FVII) deficiency is a rare autosomal recessive bleeding disorder. The aims of this study were to identify and verify the pathogenic mutation sites in a family with hereditary coagulation FVII deficiency, and preliminarily explore the underlying mechanisms. We identified a novel combination of compound heterozygous mutations, c.572-1G>A and c.1037A>C in F7 gene, associated with FVII deficiency. The splice site mutation c.572-1G>A led to a truncation, resulting in the loss of the essential catalytic domain of the FVII protein. The c.1037A>C missense mutation has not been previously reported. Our study revealed that this mutation leads to steric hindrance between residues, causing significant changes in the energy and structure of the FVII protein, ultimately affecting its function. These changes disrupt the normal function of the FVII protein, accelerating the development of inherited FVII deficiency. Moreover, the mRNA expression of the F7 gene and the protein expression of the FVII antigen (FVII: Ag) were significantly lower in the proband, as well as in the proband's parents, compared to the healthy control (P<0.05). Our findings not only elucidate the genetic underpinning of FVII deficiency in the family studied but also contribute a new mutation to the known disease spectrum, potentially assisting in future diagnostic and therapeutic approaches.
Identification of Genetic Defects Underlying FXII Deficiency in Four Unrelated Chinese Patients

Lihong Yang,Yingyu Wang,Jianpin Zhou,Xiaoli Cheng,Xiuping Hao,Haixiao Xie,Yanhui Jin,Mingshan Wang

DOI: https://doi.org/10.1159/000444209

2016-01-01

Acta Haematologica

Abstract:Congenital factor XII (FXII) deficiency is a rare autosomal recessive disorder, characterized by a great variability in its clinical manifestations. In this study, we screened for mutations in the F12 gene of 4 unrelated patients with FXII coagulant activity <10% of that of normal human plasma. To investigate the molecular defects in these FXII-deficient patients, we performed FXII mutation screening. By sequencing all coding exons as well as flanking intronic regions of the F12 gene, 6 different mutations, including 3 missense mutations (Gly341Arg, Glu502Lys and Gly542 Ser), 1 insertion (7142insertC) and 2 deletions (5741-5742 delCA and 6753-6755delACA), were identified on the F12 gene. Three of them (Gly341Arg, 5741-5742delCA and 6753-6755delACA) are reported here for the first time. Computer-based algorithms predicted these missense mutations to be deleterious. This study has increased our knowledge of the mutational spectrum underlying FXII deficiency.

hematology
Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China

Li Yuan,Wei Chen,Xiaoqin Wang,Heng Zhang

DOI: https://doi.org/10.1097/MBC.0000000000001061

2021-01-01

Blood Coagulation & Fibrinolysis

Abstract:Congenital coagulation factor XI (FXI) deficiency is a rare bleeding disorder with a heterogeneous haemorrhagic phenotype and various hotspot gene mutations associated with race and geography. Studies on FXI deficiency in Shaanxi Province, China, are scarce. In this study, seven patients with severe FXI deficiency and several family members were analysed. The International Society on Thrombosis and Hemostasis-Bleeding Assessment Tool (ISTH-BAT) was applied to assess bleeding symptoms. FXI activity was determined using a one-stage method, and the FXI antigen was measured by enzyme-linked immunosorbent assay. Targeted capture next-generation sequencing and Sanger sequencing were applied to detect FXI gene mutations. The bleeding phenotype varied, although none of the participants had a history of spontaneous bleeding. One maternal received replacement therapy during the perinatal period, one female patient presented with menorrhagia, one male patient experienced severe postoperative bleeding and others were asymptomatic. Family members with heterozygous mutations were all asymptomatic. The FXI activity of all the patients ranged from less than 1 to 3.1 IU/dl, and a synchronous decrease in the FXI antigen was observed. Two missense mutations (p. Gly350Glu and p. Cys482Trp), one nonsense mutation (p. Gln384M) and one novel frameshift mutation (p. Ser225PhefsM16) were detected. The bleeding manifestations and severity of severe FXI deficiency varied and were not related to its activity. Three reported mutations and one novel frameshift mutation were identified, thus extending the mutation spectrum of FXI deficiency. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
[Identification of Two Novel Mutation in Two Chinese Hereditary Coagulation Factor XIII Deficiency Families].

Baohua Duan,Hongli Wang,Haiyan Chu,Xuefeng Wang,Bin Qu,Dao Li,Hong Wang,Jun Yin,Wenying Kang,Zhenyi Wang

DOI: https://doi.org/10.3760/j:issn:0253-2727.2002.03.001

2002-01-01

Abstract:OBJECTIVE:To explore gene defect of hereditary coagulation factor XIII deficiency.METHODS:PCR and gene sequencing or ARMS-PCR were used to detect the FXIIIA gene of peripheral white blood cell (PBC) from two Chinese hereditary coagulation factor XIII deficiency family members and 60 normal subjects respectively. The level of FXIIIA gene mRNA was tested by RT-PCR.RESULTS:(1) Nucleotide sequence analysis of the two probands' and their family members' DNA revealed that all of the three patients had homozygous missense mutation in FXIII A subunit gene. Proband 1 had a C to G transition at nucleotide (nt) 1 241 in exon 10 and proband 2 and his sister a C to T transition at nt 232 in exon 3 of FXIII A gene, which resulted in the substitution of Ser413 with Trp and Arg 77 with Cys, respectively. Family study showed that the two mutations were inherited from the parents who were correspondingly heterozygotes at nt 1 241 or nt 232. (2) The two mutations were not found in the normal subjects. (3) The FXIIIA gene mRNA level in the two probands was a little decreasing.CONCLUSION:It is the two novel mutations that results in FXIIIA deficiency. The two mutations of FXIIIA gene may affect its function or alter protein folding. The defective FXIII which is unstable and degraded rapidly in cytoplasm may be the main cause of FXIII deficiency.
A Case of Factor XI Deficiency Caused by Compound Heterozygous F11 Gene Mutation

Jing Wang,Xuefeng Wang,Jing Dai,Qiulan Ding,Qihua Fu,Hongli Wang,Lisong Shen,Dao Li

DOI: https://doi.org/10.1111/j.1365-2516.2008.01937.x

2009-01-01

Haemophilia

Abstract:Inherited factor XI (FXI) deficiency is a rare autosomal recessive bleeding disorder in most populations except for Ashkenazi Jews. In this report, a 25-year-old Chinese female FXI deficiency case has been studied. Routine clotting tests showed significantly prolonged activated partial thromboplastin time (69.5 s, control 35 +/- 10 s) while prothrombin time (12.3 s, control 13 +/- 3 s)was normal. FXI:C and FXI:Ag were 2.6% and 2.5%, respectively, indicating that this case was cross-reacting material negative. The activities of other coagulation factors and liver function were in normal range. The DNA sequence results of the 15 exons and their boundaries of F11 gene revealed a novel G3733C missense mutation in exon 2, and a recurrent C16642T nonsense mutation in exon 8. The G3733C mutation caused G-1R substitution in FXI signal peptide, which might impair the protein's secretion and introduced a new BssSI enzyme digestion site. The C16642T mutation led a premature stop codon at amino acid position 263(Q263Term). G-1R and Q263Term compound heterozygous mutations in F11 gene were the cause of FXI deficiency for this proband. G-1R mutation was a novel F11 gene mutation causing inherited FXI deficiency.
[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].

D L Zhang,F Xue,X Q Dou,X F Liu,R F Fu,Y F Chen,W Liu,Y J Jia,Y H Wang,Z J Xiao,L Zhang,R C Yang

DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2021.04.006

2021-01-01

Abstract:Objective: To analyze the clinical phenotype and molecular pathogenesis of nine patients with hereditary factor Ⅴ (FⅤ) deficiency. Methods: Nine patients with hereditary FⅤ deficiency who were admitted to the Institute of Hematology and Blood Diseases Hospital from April 1999 to September 2019 were analyzed. The activated partial thromboplastin time, prothrombin time, and FⅤ procoagulant activity (FⅤ∶C) were measured for phenotypic diagnosis. High-throughput sequencing was employed for the F5 gene mutation screening, Sanger sequencing was adopted to confirm candidate variants and parental carrying status, Swiss-model was used for three-dimensional structure analysis, and ClustalX v.2.1 was used for homologous analysis. Results: The FⅤ∶C of the nine patients ranged from 0.1 to 10.6. Among them, eight had a hemorrhage history, with kin/mucosal bleeding as the most common symptom (three cases, 37.5%) , whereas one case had no bleeding symptom. There were five homozygotes and four compound heterozygotes. A total of 12 pathogenic or likely pathogenic mutations were detected, of which c.6100C>A/p.Pro2034Thr, c.6575T>C/p.Phe2192Ser, c.1600_1601delinsTG/p. Gln534*, c.4713C>A/p.Tyr1571*, and c.952+5G>C were reported for the first time. Conclusion: The newly discovered gene mutations enriched the F5 gene mutation spectrum associated with hereditary FⅤ deficiency. High-throughput sequencing could be an effective method to detect F5 gene mutations.

Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations

The Molecular Genetic Analysis of Coagulation Factor XI (FXI) Deficiency in Two Chinese Patients

A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree

[Phenotype and genotype analysis for a consanguineous pedigree with combined coagulation factor VII and X deficiency].

Genetic Analysis in Factor XI Deficient Patients from Central China: Identification of One Novel and Seven Recurrent Mutations.

[FXI Gene Mutations in Two Pedigrees of Congenital Clotting Factor XI Deficiency].

Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

Molecular analysis of the discrepancy between the genotypes and phenotypes in a inherited coagulation factor Ⅶ deficiency.

Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency

Genetic Analysis of a Pedigree with Combined Factor XII and Factor XI Deficiency

Study on the molecular mechanism of the inherited factor X deficiency in three unrelated families

[The Inherited Coagulation Factor XI Deficiency Caused by Intronic Mutation IVS J-4delgttg].

Inherited coagulation factor X deficiency caused by two novel mutations in factor X gene]

Molecular Defects in the Factor X Gene Caused by Novel Heterozygous Mutations IVS5+1G>A and Asp409del.

Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China

Hereditary Coagulation Factor VII Deficiency Caused by Novel Compound Heterozygous Mutations C.572-1G>a and C.1037a>c in a Chinese Pedigree

Identification of Genetic Defects Underlying FXII Deficiency in Four Unrelated Chinese Patients

Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China

[Identification of Two Novel Mutation in Two Chinese Hereditary Coagulation Factor XIII Deficiency Families].

A Case of Factor XI Deficiency Caused by Compound Heterozygous F11 Gene Mutation

[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].